**Core Concept**
Olazapine, a second-generation antipsychotic, exhibits a unique pharmacological profile that sets it apart from other antipsychotics. It has a broad range of actions, including antagonism at dopamine D2 and serotonin 5-HT2A receptors, which contribute to its therapeutic effects. However, its pharmacological properties also lead to various side effects and interactions.

**Why the Correct Answer is Right**
The statement that olazapine has less epileptogenic action than phenothiazine is incorrect. Phenothiazines are known to have a lower risk of inducing seizures compared to olanzapine. This is because phenothiazines tend to block dopamine receptors in a more balanced manner, whereas olanzapine preferentially blocks D2 receptors, which can increase the risk of seizures. Additionally, olanzapine's mechanism of action involves the blockade of multiple neurotransmitter receptors, including 5-HT2A and H1 receptors, which can also contribute to its potential to induce seizures.

**Why Each Wrong Option is Incorrect**
**Option A:** Olanzapine is indeed associated with marked anti-muscarinic action, which can lead to side effects such as dry mouth, constipation, and urinary retention. This is due to its blockade of muscarinic acetylcholine receptors.
**Option B:** Weight gain is a well-documented side effect of olanzapine, which is thought to be related to its blockade of 5-HT2C receptors, leading to increased appetite and food intake.
**Option C:** Olanzapine can cause a mild increase in prolactin levels due to its blockade of dopamine D2 receptors, which regulate prolactin secretion. This can lead to side effects such as galactorrhea and amenorrhea.

**Clinical Pearl / High-Yield Fact**
When prescribing antipsychotics like olanzapine, it is essential to carefully weigh the potential benefits against the risks of side effects, particularly those related to metabolism and weight gain. Regular monitoring of weight and metabolic parameters is crucial to prevent long-term complications.

**✓ Correct Answer: D. Less epileptogenic action than phenothiazine**